US Bancorp

US Bancorp’s Lexicon Pharmaceuticals LXRX Stock Holding History

US Bancorp’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,082	Closed	-$499	–	4264
2025 Q1	$499	Sell	1,082 -542	-33%	-$342	﹤0.01%	4041
2024 Q4	$1.2K	Buy	+1,624	New	+$1.96K	﹤0.01%	3939
2024 Q2	–	Sell	-1,200	Closed	-$2.88K	–	4052
2024 Q1	$2.88K	Buy	+1,200	New	+$2.58K	﹤0.01%	3653
2018 Q4	–	Sell	-128	Closed	-$1K	–	3641
2018 Q3	$1K	Hold	128	–	–	﹤0.01%	3574
2018 Q2	$2K	Buy	+128	New	+$1.31K	﹤0.01%	3486
2017 Q4	–	Sell	-108	Closed	-$1K	–	3643
2017 Q3	$1K	Sell	108 -1,077	-91%	-$15.9K	﹤0.01%	3497
2017 Q2	$19K	Buy	1,185 +1,021	+623%	+$15.8K	﹤0.01%	2897
2017 Q1	$2K	Buy	164 +135	+466%	+$2K	﹤0.01%	3400
2016 Q4	$0	Buy	+29	New	+$465	﹤0.01%	3591

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.26B AUM 47.23% 1-Year Est. Return

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

CIBC Private Wealth Group

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return